These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20805740)

  • 1. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
    Schilling PJ
    Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
    Falit BP; Gross CP; Roberts KB
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organization and economics of prostate seed implantation programs.
    Wodinsky HB; Porter A; Silverstein M; Pontes E
    J Oncol Manag; 1998; 7(3):16-20. PubMed ID: 10181576
    [No Abstract]   [Full Text] [Related]  

  • 6. The paradox of multidisciplinary care.
    Potters L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):20-2. PubMed ID: 22901419
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
    Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The negative impact of stark law exemptions on graduate medical education and health care costs: the example of radiation oncology.
    Anscher MS; Anscher BM; Bradley CJ
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1289-94. PubMed ID: 20338471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of imaging: challenges and opportunities.
    Thrall JH
    J Am Coll Radiol; 2009 May; 6(5):287-8. PubMed ID: 19394564
    [No Abstract]   [Full Text] [Related]  

  • 10. Adoption of health promotion practices in a cohort of U.S. physician organizations.
    Bellows NM; McMenamin SB; Halpin HA
    Am J Prev Med; 2010 Dec; 39(6):555-8. PubMed ID: 21084076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation treatment of lung cancer--patterns of practice in Canada.
    Tai P; Yu E; Battista J; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):167-74. PubMed ID: 15110450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensity Modulated Radiation Therapy (IMRT)].
    Maebayashi K; Nasu S; Seki K; Kiyoduka M; Hashimoto Y; Mitsuhashi N
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):436-43. PubMed ID: 16612150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative radiation therapy in the United States.
    Coia LR
    Can J Oncol; 1996 Feb; 6 Suppl 1():62-8; discussion 84. PubMed ID: 8853540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing management of localized prostate cancer: a comparison survey of Ontario radiation oncologists.
    Martin J; Rodrigues G; Malone S; Morton G; Campbell H; Crook J
    Can J Urol; 2006 Apr; 13 Suppl 2():26-33. PubMed ID: 16672125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician investment in the health care industry: a concern.
    Watts C
    Surg Neurol; 2009 Oct; 72(4):401-2. PubMed ID: 18786706
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.
    Guckenberger M; Flentje M
    Strahlenther Onkol; 2007 Feb; 183(2):57-62. PubMed ID: 17294108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
    Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
    J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.